End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.022 AUD | 0.00% | +10.00% | +10.00% |
30/04 | Transcript : Syntara Limited, Q3 2024 Earnings Call, Apr 30, 2024 | |
10/04 | Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.00% | 1.75Cr | |
+43.64% | 75TCr | |
+39.42% | 63TCr | |
-6.58% | 35TCr | |
+19.72% | 33TCr | |
+8.78% | 30TCr | |
+11.92% | 22TCr | |
-2.62% | 22TCr | |
+0.03% | 16TCr | |
+6.13% | 16TCr |
- Stock Market
- Equities
- SNT Stock
- News Syntara Limited
- Nature Communications Publishes Preclinical Data on Pharmaxis' Cancer Drug Therapy in Blood Cancer